RGM Capital’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BC
RA
SAM
RGM Capital's ANGO Position: Q3 2017 in Review
RGM Capital sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 707,497 shares — an estimated $11.5M sold.
RGM Capital first reported a position in ANGO in Q2 2013 and held it in 17 quarters. The position peaked at $59M in Q4 2013. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.
- RGM Capital reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
- RGM Capital sold 707,497 AngioDynamics shares in Q3 2017, an estimated $11.5M.
- RGM Capital first reported a position in AngioDynamics in Q2 2013 and held it in 17 quarters.
- RGM Capital's AngioDynamics position peaked at $59M in Q4 2013.
- 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.
Based on RGM Capital's 13F filing for Q3 2017, filed 14 Nov 2017.